NeueHealth, Inc. (NYSE:NEUE – Get Free Report) CFO Jay Matushak sold 4,970 shares of the firm’s stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $7.33, for a total transaction of $36,430.10. Following the transaction, the chief financial officer now owns 17,747 shares in the company, valued at $130,085.51. This represents a 21.88 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
NeueHealth Trading Down 1.2 %
Shares of NeueHealth stock opened at $7.33 on Friday. NeueHealth, Inc. has a 52 week low of $3.79 and a 52 week high of $16.59. The stock has a market cap of $60.73 million, a PE ratio of -0.14 and a beta of 0.57. The company’s 50-day moving average price is $5.60 and its two-hundred day moving average price is $5.42.
Analyst Upgrades and Downgrades
Separately, Royal Bank of Canada lowered their price target on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research report on Monday, December 9th.
Institutional Trading of NeueHealth
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. NEA Management Company LLC bought a new stake in NeueHealth during the second quarter worth approximately $14,834,000. Deer Management Co. LLC acquired a new stake in shares of NeueHealth during the 2nd quarter valued at $5,436,000. Partners Group Holding AG bought a new stake in shares of NeueHealth during the 3rd quarter worth $463,000. Finally, Renaissance Technologies LLC acquired a new position in shares of NeueHealth in the 2nd quarter worth $312,000. 63.88% of the stock is currently owned by institutional investors.
NeueHealth Company Profile
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Further Reading
- Five stocks we like better than NeueHealth
- How to Invest in Biotech Stocks
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Golden Cross Stocks: Pattern, Examples and Charts
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Stock Market Sectors: What Are They and How Many Are There?
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.
